James P. Kelly
2016 - Vanda Pharmaceuticals
In 2016, James P. Kelly earned a total compensation of $2.2M as Executive Vice President, Chief Financial Officer and Treasurer at Vanda Pharmaceuticals, a 91% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $202,800 |
|---|---|
| Option Awards | $548,800 |
| Salary | $390,000 |
| Stock Awards | $1,015,000 |
| Other | $32,429 |
| Total | $2,189,029 |
Kelly received $1M in stock awards, accounting for 46% of the total pay in 2016.
Kelly also received $202.8K in non-equity incentive plan, $548.8K in option awards, $390K in salary and $32.4K in other compensation.
Rankings
In 2016, James P. Kelly's compensation ranked 4,482nd out of 14,075 executives tracked by ExecPay. In other words, Kelly earned more than 68.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,482 out of 14,075 | 68th |
Division Manufacturing | 1,583 out of 5,486 | 71st |
Major group Chemicals And Allied Products | 483 out of 1,900 | 75th |
Industry group Drugs | 354 out of 1,543 | 77th |
Industry Pharmaceutical Preparations | 277 out of 1,173 | 76th |
Source: SEC filing on April 27, 2017.
Kelly's colleagues
We found four more compensation records of executives who worked with James P. Kelly at Vanda Pharmaceuticals in 2016.